Sana Biotechnology, Inc.
USD3.24
+0.03 (+0.93%)
CEO
Steven D. Harr
IPO Date
2021-02-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.15
Prev. Close
$3.21
Day Low
$3.05
Day High
$3.28
52W Low
$2.10
52W High
$6.55
Market Cap
$0.90B
Volume
3.21M
| 0 |
| $0.00 |
| 27 Mar 2026 | PATEL DHAVALKUMAR DHIRAJLAL | EVP, Chief Scientific Officer | Disposed | 515,000 | $5.84 |
| 27 Mar 2026 | PATEL DHAVALKUMAR DHIRAJLAL | EVP, Chief Scientific Officer | Disposed | 375,000 | $2.55 |
| 27 Mar 2026 | PATEL DHAVALKUMAR DHIRAJLAL | EVP, Chief Scientific Officer | Disposed | 506,250 | $3.41 |
| 27 Mar 2026 | PATEL DHAVALKUMAR DHIRAJLAL | EVP, Chief Scientific Officer | Disposed | 112,500 | $0.00 |
| 10 Mar 2026 | Harr Steve | director, officer: President & CEO | M-Exempt | Acquired | 41,666 | $0.00 |
| 10 Mar 2026 | Harr Steve | director, officer: President & CEO | M-Exempt | Acquired | 50,000 | $0.00 |
| 10 Mar 2026 | Harr Steve | director, officer: President & CEO | F-InKind | Disposed | 11,526 | $3.13 |
| 10 Mar 2026 | Harr Steve | director, officer: President & CEO | F-InKind | Disposed | 12,819 | $3.10 |